Literature DB >> 10755412

Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.

P Brennan1, M Coates, B Armstrong, D Colin, P Boffetta.   

Abstract

The incidence of non-Hodgkin's lymphoma (NHL) has been increasing rapidly over the last three decades. The reasons for this trend are not known although increasing exposure to sunlight has been postulated. We used data from the New South Wales Central Cancer Registry to analyse second primary neoplasms following NHL diagnosed between 1972 and 1995, to identify possible common causal agents. A total of 12,452 patients contributed 54,308 person-years of follow-up during which time there were 705 second primary neoplasms compared to 592.99 expected (standardized incidence ratio (SIR = 1.19, 95% confidence interval (CI) 1.10-1.28). There were excesses of melanomas of skin (SIR = 2.38, 95% CI 1.92-2.91), lip cancer (SIR = 2.74, 95% CI 1.59-4.38), tongue cancer (SIR = 2.53, 95% CI 1.09-4.99) and bladder cancer (SIR = 1.64, 95% CI 1.19-2.21). There was also over a threefold excess in soft tissue sarcomas (SIR = 3.61, 95% CI 1.80-6.45) and in thyroid cancer (SIR = 3.42, 95% CI 1.56-6.49). The SIR for myeloid leukaemia was 0.78 (95% CI 0.28-1.69). The increases in melanoma of the skin and cancer of the lip and tongue among patients with NHL strongly suggest sunlight exposure as a shared causal agent. The increase in soft tissue sarcomas might be due to shared effects of exposure to chemicals such as phenoxy acid herbicides. The increases in bladder and thyroid cancers are likely to be explained by effects of treatment for NHL. We did not find a chemotherapy related increased risk of myeloid leukaemia among NHL patients.

Entities:  

Mesh:

Year:  2000        PMID: 10755412      PMCID: PMC2374485          DOI: 10.1054/bjoc.1999.1102

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study.

Authors:  M Kogevinas; H Becher; T Benn; P A Bertazzi; P Boffetta; H B Bueno-de-Mesquita; D Coggon; D Colin; D Flesch-Janys; M Fingerhut; L Green; T Kauppinen; M Littorin; E Lynge; J D Mathews; M Neuberger; N Pearce; R Saracci
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

2.  Second cancers following non-Hodgkin's lymphoma.

Authors:  L B Travis; R E Curtis; J D Boice; B F Hankey; J F Fraumeni
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

3.  Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.

Authors:  L B Travis; R E Curtis; B Glimelius; E J Holowaty; F E Van Leeuwen; C F Lynch; A Hagenbeek; M Stovall; P M Banks; J Adami
Journal:  J Natl Cancer Inst       Date:  1995-04-05       Impact factor: 13.506

4.  Risk of leukemia following treatment for non-Hodgkin's lymphoma.

Authors:  L B Travis; R E Curtis; M Stovall; E J Holowaty; F E van Leeuwen; B Glimelius; C F Lynch; A Hagenbeek; C Y Li; P M Banks
Journal:  J Natl Cancer Inst       Date:  1994-10-05       Impact factor: 13.506

5.  Non-Hodgkin's lymphoma: time trends for incidence and survival in Côte-d'Or, France.

Authors:  I Rolland-Portal; M A Tazi; C Milan; C Couillault; P M Carli
Journal:  Int J Epidemiol       Date:  1997-10       Impact factor: 7.196

6.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.

Authors:  K H Kraemer; M M Lee; A D Andrews; W C Lambert
Journal:  Arch Dermatol       Date:  1994-08

Review 7.  The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight.

Authors:  R Cartwright; R McNally; A Staines
Journal:  Leuk Lymphoma       Date:  1994-08

8.  Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?

Authors:  A J McMichael; G G Giles
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  8 in total
  10 in total

1.  Cholangiocarcinoma following external beam radiotherapy: A report of two cases.

Authors:  Anisha Kulkarni; Justin S Gundara; Anthony J Gill; Thomas J Hugh; Jaswinder S Samra
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

2.  Induction of B-cell lymphoma by UVB radiation in p53 haploinsufficient mice.

Authors:  Nahum Puebla-Osorio; Yasuko Miyahara; Sreevidya Coimbatore; Alberto Y Limón-Flores; Nasser Kazimi; Stephen E Ullrich; Chengming Zhu
Journal:  BMC Cancer       Date:  2011-01-26       Impact factor: 4.430

3.  Second malignancies in patients with primary central nervous system lymphoma.

Authors:  Jun Wang; Jose S Pulido; Brian Patrick O'Neill; Patrick B Johnston
Journal:  Neuro Oncol       Date:  2014-06-19       Impact factor: 12.300

4.  A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma.

Authors:  Jeffrey M Farma; Jonathan S Zager; Victor Barnica-Elvir; Christopher A Puleo; Suroosh S Marzban; Dana E Rollison; Jane L Messina; Vernon K Sondak
Journal:  Ann Surg Oncol       Date:  2012-11-20       Impact factor: 5.344

5.  Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.

Authors:  Elizabeth C Bluhm; Cécile Ronckers; Robert J Hayashi; Joseph P Neglia; Ann C Mertens; Marilyn Stovall; Anna T Meadows; Pauline A Mitby; John A Whitton; Sue Hammond; Joseph D Barker; Sarah S Donaldson; Leslie L Robison; Peter D Inskip
Journal:  Blood       Date:  2008-02-07       Impact factor: 22.113

6.  Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors.

Authors:  Alessia Bari; Luigi Marcheselli; Raffaella Marcheselli; Eliana Valentina Liardo; Samantha Pozzi; Paola Ferri; Stefano Sacchi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-20       Impact factor: 2.576

7.  Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma.

Authors:  P Brennan; G Scélo; K Hemminki; L Mellemkjaer; E Tracey; A Andersen; D H Brewster; E Pukkala; M L McBride; E V Kliewer; J M Tonita; A Seow; V Pompe-Kirn; C Martos; J G Jonasson; D Colin; P Boffetta
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

8.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.

Authors:  C Dong; K Hemminki
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

9.  Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.

Authors:  D B McKenna; D Stockton; D H Brewster; V R Doherty
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

10.  Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study.

Authors:  Joel Joelsson; Tove Wästerlid; Richard Rosenquist; Lasse Hjort Jakobsen; Tarec C El-Galaly; Karin E Smedby; Sandra Eloranta
Journal:  Blood Adv       Date:  2022-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.